European regulators have become the first to approve Pfizer Inc.'s Prevenar 13 vaccine for patients at all stages of life by including adults between the ages of 18 and 49.
Jul 10, 2013
0
0
Trials of new vaccine candidates must be accelerated and existing vaccine use stepped up to prevent life-threatening infections that can no longer be beaten by antimicrobial medicines, the World Health Organization (WHO) ...
Jul 20, 2022
0
4
It is well known that COPD patients run a higher risk of contracting respiratory infections. However, a new thesis from Lund University in Sweden shows that they are also at higher risk of other bacterial infections, such ...
Jan 16, 2013
0
0
Ear pain is one of the most common reasons that young children go to the doctor, and acute otitis media—which means "middle ear infection"—is the most frequent cause for the use of antibiotics in children under 5 years ...
Sep 21, 2021
0
7
Children who receive a vaccine to prevent blood and ear infections, appear to be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults. Results of a new Vanderbilt ...
Jul 10, 2013
0
0
Otitis media, more commonly known as ear infection, is the leading cause of pediatric health care visits and the most frequent reason children are prescribed antibiotics or undergo surgery. Researchers from the University ...
Nov 25, 2013
0
0
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
May 22, 2013
0
0
The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek ...
Oct 10, 2014
0
0
Pfizer's blockbuster vaccine against pneumonia and other bacterial infections has won another approval, for use in European Union residents aged 18 and older.
Mar 3, 2015
0
3
Researchers plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier generation vaccine against pneumonia and other pneumococcal diseases.
Oct 15, 2012
0
0
